What Makes Us TIC?

What Makes Us TIC?

Oct 18, 2017 2:30 PM

The Utah Trial Innovation Center, or Utah TIC, was funded by the NIH National Center for Advancing Translational Science (NCATS) in July 2016, and is part of the larger Trial Innovation Network. The seven-year, $25 million grant was awarded to Dr. J. Michael Dean, MD, MBA, professor and vice chairman for research in the Department of Pediatrics. The Trial Innovation Network is an exciting opportunity and combines three TICs (Utah, Johns Hopkins/Tufts, Duke/Vanderbilt) with one Recruitment Innovation Center (Vanderbilt), and approximately 60 existing CTSA Program Hubs, including the Utah Center for Clinical & Translational Science (CCTS).

The vision for the network is to address critical roadblocks in clinical trials and to accelerate the translation of novel interventions into life-saving therapies while implementing innovation every step of the way. Operational innovation, operational excellence and collaboration are the network cornerstones. For more information, visit the Trial Innovation Network website.

The Utah TIC has helped to provide financial support for key University of Utah clinical research stakeholders and infrastructure, including the Data Coordinating Center, the Institutional Review Board, the Office of Sponsored Projects, the Clinical Trials Office and the CCTS. This newsletter provides a forum for disseminating information about these valuable Institutional collaborations and the progressive work being done here in the intermountain west.